ALLO

Allogene Therapeutics
$1.75
+$0.01 (+0.57%)Jul 27, 2026
2.6FairMoatMint rating

MoatMint rates Allogene Therapeutics (ALLO) 2.6 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 1.9 out of 10.

Key metrics

The numbers that frame ALLO today
Market cap
$604.02M
P/E (TTM)
-3.5
EV / FCF
-5.1
ROIC
-49.8%
Div yield
0%
Debt / equity
0.0
52wk Low
$0.98
52wk High
$4.46

ALLO stock rating

How ALLO scores on quality, value, growth, momentum and financial health
2.6out of 10
Fair overallFair business, expensive priceTop 74% of ~5,000 US stocks
QualityPoor1.9/10
GrowthFair3.2/10
MomentumGreat8.3/10
ValuePoor1.4/10
Financial HealthFair2.8/10

Growth

Revenue and earnings trend for ALLO
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about ALLO
Is Allogene Therapeutics a good buy?
Hold. Allogene Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks weak. That could put pressure on the long-term business case. We think Allogene Therapeutics is selling at a very high price.
What is the market capitalization of ALLO?
Allogene Therapeutics's market capitalization is $604.02M.
What is the P/E ratio for ALLO stock?
Allogene Therapeutics's current P/E ratio is -3.5.
What is the 52-week high for ALLO stock?
The 52-week high for Allogene Therapeutics is $4.46. The current close of $1.75 is 60.8% below that high.
What is the 52-week low for ALLO stock?
The 52-week low for Allogene Therapeutics is $0.98. The current close of $1.75 is 77.8% above that low.
Does ALLO stock pay dividends?
Allogene Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ALLO?
Allogene Therapeutics's Debt / Equity ratio is 0.